Tavio Capital as of June 30, 2018
Portfolio Holdings for Tavio Capital
Tavio Capital holds 17 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | 13.5 | $40M | 363k | 109.94 | |
| Anthem (ELV) | 13.3 | $39M | 165k | 238.03 | |
| AmerisourceBergen (COR) | 9.4 | $28M | 327k | 85.27 | |
| CVS Caremark Corporation (CVS) | 9.4 | $28M | 430k | 64.35 | |
| Centene Corporation (CNC) | 7.0 | $21M | 169k | 123.21 | |
| Alexion Pharmaceuticals | 6.9 | $21M | 165k | 124.15 | |
| Hca Holdings (HCA) | 6.9 | $20M | 197k | 102.60 | |
| Humana (HUM) | 5.4 | $16M | 53k | 297.62 | |
| Boston Scientific Corporation (BSX) | 4.8 | $14M | 435k | 32.70 | |
| Heron Therapeutics (HRTX) | 3.6 | $11M | 277k | 38.85 | |
| UnitedHealth (UNH) | 3.5 | $10M | 42k | 245.34 | |
| Aetna | 3.4 | $10M | 55k | 183.50 | |
| Molina Healthcare (MOH) | 3.4 | $10M | 102k | 97.94 | |
| Celgene Corporation | 3.4 | $10M | 125k | 79.42 | |
| Retrophin | 2.7 | $8.0M | 294k | 27.26 | |
| Amicus Therapeutics (FOLD) | 2.1 | $6.3M | 403k | 15.62 | |
| Zogenix | 1.2 | $3.5M | 80k | 44.20 |
